GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-38 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.684 | 31382448
|
NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-38 | Dasatinib | Western Blotting followed by qRT-PCR | NA | 0.48 | 0.5461 | 31382448
|
NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-38 | Saracatinib | Western Blotting followed by qRT-PCR | NA | 0.48 | 0.5461 | 31382448
|
POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-38 | Dasatinib | Western Blotting followed by qRT-PCR | NA | 0.48 | 0.6448 | 31382448
|
POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-38 | Saracatinib | Western Blotting followed by qRT-PCR | NA | 0.48 | 0.6448 | 31382448
|
SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-38 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.5695 | 31382448
|